Ginkgo Bioworks news - the latest biotech news from Labiotech.eu

Ginkgo Bioworks boosts gene therapy capacity with StrideBio asset acquisition

Jim Cornall — Wed, 05 Apr 2023 13:00:00 +0000

Ginkgo Bioworks has acquired StrideBio’s adeno-associated virus (AAV) capsid discovery and engineering platform assets. A secondary close is scheduled upon the transfer of certain additional in-license agreements to Ginkgo Bioworks. Ginkgo Bioworks will incorporate the assets and IP into its end-to-end AAV gene therapy development platform, allowing the company’s customers to leverage new tools to […]

The post Ginkgo Bioworks boosts gene therapy capacity with StrideBio asset acquisition appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Ginkgo Bioworks launches Ginkgo Enzyme Services

Jim Cornall — Fri, 09 Dec 2022 11:22:14 +0000

Ginkgo Bioworks has announced the launch of Ginkgo Enzyme Services. Ginkgo Enzyme Services is powered by ultra high throughput screening and machine learning-guided protein design, as well as optimized proprietary bacterial and fungal host strains. Ginkgo Enzyme Services solves challenges for R&D teams developing enzymes, from discovery of novel enzyme activity through optimization of enzyme […]

The post Ginkgo Bioworks launches Ginkgo Enzyme Services appeared first on Labiotech.eu.

Ginkgo Bioworks acquires Altar and Circularis

Jim Cornall — Tue, 04 Oct 2022 12:50:47 +0000

Ginkgo Bioworks has announced the acquisition of two biotech companies, Altar, a French firm with a proprietary adaptive evolution platform, and Circularis, which has a proprietary circular RNA and promoter screening platform. Altar acquisition A fleet of Altar’s automated adaptive laboratory evolution (ALE) instruments will be integrated into Ginkgo’s Foundry to serve customers across food and […]

The post Ginkgo Bioworks acquires Altar and Circularis appeared first on Labiotech.eu.

Ginkgo acquires Zymergen for $300M and picks up Bayer facility for $83M

Jim Cornall — Tue, 26 Jul 2022 08:21:36 +0000

U.S. cell programming company Ginkgo Bioworks has signed definitive agreements to acquire two teams and technologies. The deals are with Bayer and Zymergen. Bayer transaction The company confirmed the previously announced transaction with Bayer to expand Ginkgo’s platform capabilities in agricultural biologicals. Ginkgo will acquire Bayer’s 175,000-square-foot West Sacramento Biologics Research & Development site, team, […]

The post Ginkgo acquires Zymergen for $300M and picks up Bayer facility for $83M appeared first on Labiotech.eu.

Delayed IPOs and Market Drops Batter Biotech Stocks

Jonathan Smith — Tue, 25 May 2021 14:31:56 +0000

Stock markets worldwide have experienced painful instability in the last few months. As a result, the European biotech market has seen stock prices falling and IPOs postponed. The Covid-19 pandemic was a major disruption for stock markets across the globe at the start of 2020. However, markets like Euronext and the tech-focused Nasdaq rallied and […]

The post Delayed IPOs and Market Drops Batter Biotech Stocks appeared first on Labiotech.eu.

Bayer Launches Plant Microbiome Biotech with a Huge €84M Series A

Clara Rodríguez Fernández — Fri, 15 Sep 2017 10:33:20 +0000

Bayer and Ginkgo Bioworks are launching a new company that will develop new technologies for sustainable agriculture by engineering the plant microbiome. With the microbiome already gaining traction in the therapeutics field, Bayer has decided to take it to agriculture. In partnership with US synthetic biology upstart Ginkgo Bioworks, the German giant is creating a new […]

The post Bayer Launches Plant Microbiome Biotech with a Huge €84M Series A appeared first on Labiotech.eu.

What are the Best Countries to Recruit Biotech Talents in 2017?

External Contributor — Wed, 15 Mar 2017 07:00:27 +0000

Before the “who to recruit” phase, an important question is “where?” We ran through the top countries in which to look for talent in biotech and had a look at what you can expect from each cluster. For each one of them, we also referenced some data on the biotech, life science and research ecosystems to […]

The post What are the Best Countries to Recruit Biotech Talents in 2017? appeared first on Labiotech.eu.

French Investor Leads €60M Financial Round for the Future of DNA Synthesis

Dani Bancroft — Wed, 27 Jan 2016 15:29:17 +0000

Twist Bioscience is a San Francisco Biotech accelerating science and innovation through rapid, high-quality DNA synthesis piece of tech. And now, Twist has completed a $61 million Series D round. An improved silicon-based design compared to the traditional 96-well plates could do wonders for DNA synthesis, including major improvements in cost and time of the process. And the […]

The post French Investor Leads €60M Financial Round for the Future of DNA Synthesis appeared first on Labiotech.eu.

€41M for a Rising Star of Synthetic Biology: Ginkgo Bioworks

Philip Hemme — Mon, 03 Aug 2015 08:00:31 +0000

Once will not hurt, we’ll speak a bit about an inspiring US-based company. A synthetic biology start-up from the worlds biggest biocluster is on its road to success. Shortly after its Series A, Boston-based Ginkgo Bioworks goes on better and raises $45M (€41M). The microbe engineer makes food taste moreish and perfume smell better. And […]

The post €41M for a Rising Star of Synthetic Biology: Ginkgo Bioworks appeared first on Labiotech.eu.